Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5420]
News [12594]
Articles [172]
Editorials [5]
Conferences [246]
elearning [17]
How should we manage patients with acute lymphoblastic leukaemia during COVID...
Dr Christopher Benton - Rocky Mountain Cancer Centers, Denver, USA
How should we manage patients with acute lymphoblastic leukaemia during COVID-19? ( Dr Christopher Benton - Rocky Mountain Cancer Centers, Denver, USA )
20 Jul 2020
Why the ADAURA study is a big step forward for NSCLC
Dr Luis Raez - Memorial Cancer Institute, Florida, USA
Why the ADAURA study is a big step forward for NSCLC ( Dr Luis Raez - Memorial Cancer Institute, Florida, USA )
17 Jul 2020
An improved procedure for breast conservation surgery
Dr Sanjit Agrawal - Tata Medical Center, Kolkata, India
An improved procedure for breast conservation surgery ( Dr Sanjit Agrawal - Tata Medical Center, Kolkata, India )
17 Jul 2020
Who does the work in cancer control?
Dr Nazik Hammad - Queen's University, Kingston, Canada
Who does the work in cancer control? ( Dr Nazik Hammad - Queen's University, Kingston, Canada )
17 Jul 2020
CheckMate 459: Long-term survival outcomes with nivolumab versus sorafenib as...
Prof Bruno Sangro - University of Navarra, Pamplona, Spain
CheckMate 459: Long-term survival outcomes with nivolumab versus sorafenib as first-line treatment in aHCC ( Prof Bruno Sangro - University of Navarra, Pamplona, Spain )
15 Jul 2020
Background of the KEYNOTE-158 trial for pembrolizumab in advanced mesothelioma
Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA
Background of the KEYNOTE-158 trial for pembrolizumab in advanced mesothelioma ( Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA )
15 Jul 2020
Novel immunotherapy approaches for small cell lung cancer
Dr Triparna Sen - Memorial Sloan Kettering Cancer Center, New York City, USA
Novel immunotherapy approaches for small cell lung cancer ( Dr Triparna Sen - Memorial Sloan Kettering Cancer Center, New York City, USA )
15 Jul 2020
KEYNOTE-427 updates: First-line pembrolizumab monotherapy in patients with...
Prof Scott Tykodi - University of Washington, Seattle, USA
KEYNOTE-427 updates: First-line pembrolizumab monotherapy in patients with advanced clear cell renal cell carcinoma ( Prof Scott Tykodi - University of Washington, Seattle, USA )
14 Jul 2020
Association of gene expression with clinical outcomes in RCC patients treated...
Prof Scott Tykodi - University of Washington, Seattle, USA
Association of gene expression with clinical outcomes in RCC patients treated with pembrolizumab ( Prof Scott Tykodi - University of Washington, Seattle, USA )
14 Jul 2020
Renal cell cancer: Highlights from ASCO 2020
Prof Scott Tykodi - University of Washington, Seattle, USA
Renal cell cancer: Highlights from ASCO 2020 ( Prof Scott Tykodi - University of Washington, Seattle, USA )
13 Jul 2020
FRACTION-RCC: Evaluating nivolumab plus ipilimumab in patients with treatment...
Prof Scott Tykodi - University of Washington, Seattle, USA
FRACTION-RCC: Evaluating nivolumab plus ipilimumab in patients with treatment-refractory advanced renal cell carcinoma ( Prof Scott Tykodi - University of Washington, Seattle, USA )
13 Jul 2020
CAPIRI versus irinotecan for the treatment of advanced gall bladder cancer...
Dr Anant Ramaswamy - Tata Memorial Hospital, Mumbai, India
CAPIRI versus irinotecan for the treatment of advanced gall bladder cancer patients progressing on first-line chemotherapy ( Dr Anant Ramaswamy - Tata Memorial Hospital, Mumbai, India )
13 Jul 2020

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation